Mylan

The Upjohn Company was a pharmaceutical manufacturing firm.

Mapi Pharma is a development-stage pharmaceutical company focused on creating high-barrier-to-entry generic drugs, including complex active pharmaceutical ingredients, formulations, and life cycle management products aimed at substantial markets. With a foundation in robust chemical and pharmaceutical research and development, Mapi leverages its understanding of global markets and regulatory requirements to establish lasting partnerships across various regions. The company is committed to delivering both generic and innovative intermediates and active pharmaceutical ingredients, as well as developing finished dosage forms for its internal programs or as generics of established brands. Headquartered in Israel, Mapi operates R&D facilities in Israel, China, and Germany, and is in the process of constructing an API manufacturing site in Neot Hovav. The company maintains a strong intellectual property position, actively filing patents for its APIs and formulations to protect its innovations.

Renaissance Acquisition Holdings offers small and mid-size pharmaceutical companies with capital, advisory services, and opportunities to connect with others in the industry. Renaissance Acquisition Holdings offers consulting services that focus on sales growth strategy development, capacity expansion, research and development, identification and recruitment of complementary management talent, development of planning and management tools, and cash flow. Renaissance Acquisition Holdings was acquired by Mylan in May 2016. Renaissance Acquisition Holdings is headquartered in Longueuil, Quebec.

Meda is an international specialty pharmaceutical company with operations in over 55 countries. They focus on sustainable growth to provide value for patients, shareholders, and stakeholders. Meda aims to be a fast-growing, innovative company dedicated to improving individuals' well-being through its prescription and non-prescription products.

Abbott, established in 1910, is a global healthcare company with a diverse portfolio of products. It is a leader in pharmaceuticals, with notable brands like Norvir (HIV treatment), Synthroid (synthetic thyroid hormone), and Humira (rheumatoid arthritis drug). In diagnostics, Abbott Molecular specializes in molecular diagnostics, offering over 350 products for infectious disease, oncology, and genetics. Abbott's medical devices division is prominent in cardiovascular and diabetes care, with products such as pacemakers, glucose monitors, and neuromodulation devices. Additionally, Abbott is a significant player in eye care, ranking first in LASIK and second in cataract surgery with its TECNIS platform. The company's nutritional division provides a range of products for both adults and infants. Abbott India, a subsidiary, focuses on women's health, gastroenterology, and metabolic disorders. Approximately 60% of Abbott's sales come from outside the United States.

Agila Specialties manufactures and markets pharmaceutical products. The company offers penicillin,cephalosporins, peptides, oncology drugs, and sterile injectables.

Zyomyx has a unique expertise in and passion for tackling difficult “outside-the-box” problems. Highly user-friendly, instrument-free point-of-care tests need to be designed with an advanced level of cartridge engineering and reagent stability, and aligned with aggressive cost targets. Zyomyx specializes in exactly these demanding product requirements. Our immediate focus is an advanced, but simple to use and inexpensive CD4 T-cell point-of-care test that will be launched globally and configured to especially meet the demanding specifications for use in low and middle income countries.

Pfizer - Respiratory Delivery Platform comprises rights to develop, manufacture and commercialize dry powder inhaler delivery platform.

Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company.

Merck Generics offers standard therapies in therapeutic areas through drugs containing active ingredients.

Matrix Laboratories Limited is a public limited company engaged in the manufacturing and supply of active pharmaceutical ingredients (APIs). The company specializes in a diverse range of products, including antibacterials, central nervous system agents, antihistamines, anti-asthmatics, cardiovascular medications, antivirals, antidiabetics, antifungals, proton pump inhibitors, and pain management drugs. Through its comprehensive portfolio, Matrix Laboratories plays a significant role in the pharmaceutical industry, catering to various therapeutic areas and contributing to the development of essential medications.

King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company engaged in the research, development, manufacturing, marketing, and sales of branded prescription pharmaceutical products and animal health products. The company's portfolio includes neuroscience products, primarily pain medications, hospital products, and established brands for human use. Additionally, King Pharmaceuticals operates an auto-injector business that specializes in delivering acute care medicines through auto-injector devices. In the animal health sector, the company focuses on medicated feed additives and water-soluble therapeutics mainly for poultry, cattle, and swine. King's operations are organized into four segments: a specialty-driven branded prescription pharmaceuticals business, a global animal health business, the Meridian auto-injector division, and revenues from royalties and other sources.

Penederm is a healthcare company that markets topically administered prescription products. It was founded by Robert Chess.